These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cardiac hypertrophy and failure--a disease of adaptation. Modifications in membrane proteins provide a molecular basis for arrhythmogenicity. Moalic JM; Charlemagne D; Mansier P; Chevalier B; Swynghedauw B Circulation; 1993 May; 87(5 Suppl):IV21-6. PubMed ID: 8485830 [TBL] [Abstract][Full Text] [Related]
23. Myocardial aging: functional alterations and related cellular mechanisms. Lakatta EG; Yin FC Am J Physiol; 1982 Jun; 242(6):H927-41. PubMed ID: 6283905 [TBL] [Abstract][Full Text] [Related]
24. [Decrease in the functional capacity of the hypertrophied heart in disturbed cellular adaptation to oxygen]. Demurov EA; Gerasimov AM; Mil'chakov VI; Koloskov IuB; Telegin IuN Dokl Akad Nauk SSSR; 1983; 270(4):1001-4. PubMed ID: 6309492 [No Abstract] [Full Text] [Related]
25. [Protective effect of berberine on cardiac hypertrophy induced by L-thyroxine in rats]. Yang J; Zhou ZY; Xu JG Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):223-5. PubMed ID: 15071923 [TBL] [Abstract][Full Text] [Related]
26. Cardiac hypertrophy: from fetal to fatal? Waldenström A; Schwartz K; Swynghedauw B Clin Physiol; 1989 Aug; 9(4):315-20. PubMed ID: 2548803 [No Abstract] [Full Text] [Related]
27. The interaction between tetrandrine, calcium ion and cardiac glycosides on various heart preparations. Chen YY; Lu FH Acta Acad Med Wuhan; 1983; 3(2):123-5. PubMed ID: 6866386 [No Abstract] [Full Text] [Related]
28. Time course alterations of myocardial endothelin-1 production during the formation of exercise training-induced cardiac hypertrophy. Iemitsu M; Maeda S; Otsuki T; Goto K; Miyauchi T Exp Biol Med (Maywood); 2006 Jun; 231(6):871-5. PubMed ID: 16741015 [TBL] [Abstract][Full Text] [Related]
29. Effects of Nigella sativa supplementation for one month on cardiac reserve in rats. Yar T; El-Hariri M; El-Bahai MN; Bamosa AO Indian J Physiol Pharmacol; 2008; 52(2):141-8. PubMed ID: 19130857 [TBL] [Abstract][Full Text] [Related]
30. Myocardial adaptation to stress from the viewpoint of evolution and development. Alpert NR; Mulieri LA Soc Gen Physiol Ser; 1982; 37():173-88. PubMed ID: 6216597 [TBL] [Abstract][Full Text] [Related]
31. Site-specific antibody of (Na(+) + K(+))-ATPase augments cardiac myocyte contraction without inactivating enzyme activity. Xu KY; Wang SQ; Cheng H Biochem Biophys Res Commun; 2001 Nov; 289(1):167-72. PubMed ID: 11708795 [TBL] [Abstract][Full Text] [Related]
32. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Shiojima I; Walsh K Genes Dev; 2006 Dec; 20(24):3347-65. PubMed ID: 17182864 [TBL] [Abstract][Full Text] [Related]
33. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins. Müller-Ehmsen J; Nickel J; Zobel C; Hirsch I; Bölck B; Brixius K; Schwinger RH Basic Res Cardiol; 2003 Mar; 98(2):90-6. PubMed ID: 12607130 [TBL] [Abstract][Full Text] [Related]
34. Electrophysiological remodeling in hypertrophy and heart failure. Tomaselli GF; Marbán E Cardiovasc Res; 1999 May; 42(2):270-83. PubMed ID: 10533566 [No Abstract] [Full Text] [Related]
35. Thyroid hormone at physiological doses restores depressed contractile reserve and impaired calcium handling of cardiac myocytes from chronically unloaded hearts. Pantos C Acta Physiol (Oxf); 2007 Mar; 189(3):219. PubMed ID: 17305701 [No Abstract] [Full Text] [Related]
36. Differential regulation of Na/K-ATPase alpha-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuli. Huang L; Kometiani P; Xie Z J Mol Cell Cardiol; 1997 Nov; 29(11):3157-67. PubMed ID: 9405189 [TBL] [Abstract][Full Text] [Related]